Drug Comparison

PillID

Pill Identifier Drug Encyclopedia Drug Classes Interactions Blog 🌙

Lexapro vs Zoloft

Escitalopram (Lexapro) and sertraline (Zoloft) are both selective serotonin reuptake inhibitors (SSRIs) and two of the most commonly prescribed antidepressants in the United States. Both are considered first-line treatments for depression and anxiety, but they differ in subtle ways that may matter for individual patients. This comparison breaks down where they overlap and where they diverge.

Quick Comparison

Feature	Escitalopram (Lexapro)	Sertraline (Zoloft)
Drug Class	SSRI	SSRI
Brand Names	Lexapro	Zoloft
Half-Life	27–32 hours	26 hours (metabolite: 62–104 hrs)
DEA Schedule	Not scheduled	Not scheduled
Pregnancy	Category C	Category C
Best For	Depression, GAD; fewest drug interactions	Depression, OCD, PTSD, social anxiety, PMDD

How They're Similar

Escitalopram and sertraline share the same fundamental mechanism: they block the serotonin transporter (SERT), preventing the reuptake of serotonin from the synapse and thereby increasing serotonergic signaling. Both are well-tolerated first-line SSRIs with decades of clinical experience behind them. They share a similar side effect profile — nausea (particularly in the first weeks), insomnia or sedation, sexual dysfunction, and a small but real risk of activating suicidal ideation in younger patients, which carries a black box warning for all SSRIs.

Both drugs typically require 2–4 weeks before meaningful antidepressant effects emerge, and neither has meaningful addiction potential or physical dependence in the way benzodiazepines do. They are both available as inexpensive generics and are on most insurance formularies at the lowest cost tier.

Key Differences

Mechanism nuance: Escitalopram is the active S-enantiomer of citalopram, and its selectivity for the serotonin transporter is among the highest of any SSRI — it has very little activity at other receptors. Sertraline also has high SERT selectivity but additionally inhibits the dopamine transporter (DAT) to a minor degree and interacts with sigma-1 receptors, which may account for some clinical differences.

FDA-approved indications: This is where they diverge meaningfully. Escitalopram is FDA-approved for major depressive disorder and generalized anxiety disorder. Sertraline carries approvals for MDD, OCD, panic disorder, PTSD, social anxiety disorder, and premenstrual dysphoric disorder (PMDD) — the broadest indication list of any SSRI.

Drug interactions: Escitalopram has fewer CYP enzyme interactions than sertraline. Sertraline is a moderate inhibitor of CYP2D6 and CYP2C19, which can affect levels of other medications. For patients on complex medication regimens, escitalopram's cleaner interaction profile is often preferred.

Side effect differences: In large head-to-head analyses (including the STAR*D trial and CANMAT meta-analyses), both drugs performed comparably, but escitalopram is often cited as slightly better tolerated with a marginally lower discontinuation rate. Sertraline may cause more gastrointestinal side effects, particularly diarrhea.

Escitalopram: Strengths & Weaknesses

Strengths: Escitalopram consistently ranks among the most well-tolerated antidepressants. Its high SERT selectivity means fewer off-target effects and drug interactions. It is a strong choice for patients who are on multiple medications or who are particularly sensitive to side effects. Its once-daily dosing and long half-life provide stable blood levels.

Weaknesses: Its narrower FDA approval list (just MDD and GAD) means it may be prescribed off-label for conditions sertraline treats on-label. It may have a slightly higher rate of QT interval prolongation at higher doses compared to other SSRIs — clinically relevant mainly in patients with pre-existing cardiac risk factors.

Sertraline: Strengths & Weaknesses

Strengths: Sertraline's breadth of FDA-approved indications makes it the go-to SSRI when anxiety disorders, OCD, PTSD, or PMDD are complicating the picture. Its long track record includes robust data in pediatric populations for OCD (it is FDA-approved in children as young as 6 for OCD). Some patients find it slightly energizing, which can be advantageous in depression with prominent fatigue.

Weaknesses: Sertraline's moderate CYP2D6 and CYP2C19 inhibition can interact with drugs like tamoxifen, certain antipsychotics, and pain medications, requiring more attention in polypharmacy scenarios. GI side effects — nausea, diarrhea — may be more pronounced than with escitalopram.

Which Is Right for You?

Prescribers often favor escitalopram when the primary diagnosis is depression or generalized anxiety, when the patient takes multiple other medications, or when tolerability is the top priority. Sertraline is often preferred when OCD, PTSD, social anxiety, or PMDD are part of the picture, when treating children or adolescents with OCD, or when depression accompanies significant fatigue (due to its mildly activating profile in some patients).

Both drugs are considered interchangeable as initial choices for straightforward MDD or GAD by many guidelines. If one SSRI fails after an adequate trial (typically at least 6–8 weeks at a therapeutic level), switching to the other is a reasonable next step — partial responders often respond differently to individual SSRIs despite sharing the same mechanism.

Frequently Asked Questions